MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
6.60
+0.29
+4.60%
After Hours: 6.97 +0.37 +5.61% 18:32 11/11 EST
OPEN
6.68
PREV CLOSE
6.31
HIGH
7.15
LOW
6.18
VOLUME
424.70K
TURNOVER
--
52 WEEK HIGH
7.15
52 WEEK LOW
3.500
MARKET CAP
134.06M
P/E (TTM)
-4.4561
1D
5D
1M
3M
1Y
5Y
1D
PolyPid Earnings Call Highlights D-PLEX100 Launch Path
TipRanks · 7h ago
PolyPid Highlights D-PLEX100 Regulatory Progress, Reports Narrower Q3 Loss; Stock Up
NASDAQ · 15h ago
PolyPid Q3 2026 Earnings Call Transcript
Benzinga · 16h ago
PolyPid reports Q3 results
Seeking Alpha · 18h ago
PolyPid Q3 EPS $(0.24) Misses $0.06 Estimate
Benzinga · 18h ago
PolyPid Nears a Potentially Transformative FDA Decision as It Advances Its Innovative Pipeline (NASDAQ: PYPD)
TipRanks · 1d ago
Weekly Report: what happened at PYPD last week (1102-1106)?
Weekly Report · 2d ago
PolyPid: Strong Phase 3 Data Support A Buy Ahead Of November's FDA Decision
Seeking Alpha · 11/04 08:44
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.